177Lu-CTR-FAPI

· Xijing Hospital

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for 177Lu-CTR-FAPI, covering 2025-06-10 to 2026-02-27. Get the full timeline:

Most recent: Clinical Trial Update: 177Lu-CTR-FAPI for the Treatment of Thyroid Cancer [Phase 1]